We are live on
!
Find out more
RE
RBC Europe Portfolio holdings
AUM
$2.08B
1-Year Est. Return
12.2%
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$852M
AUM Growth
+$34.2M
(+4.2%)
Cap. Flow
-$2.21M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
41.05%
Holding
1,206
New
80
Increased
123
Reduced
188
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$4.02M |
| 2 |
Microsoft
MSFT
|
+$2.15M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.41M |
| 4 |
Visa
V
|
+$1.37M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$905K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$4.54M |
| 2 |
Keurig Dr Pepper
KDP
|
+$3.78M |
| 3 |
MON
Monsanto Co
MON
|
+$1.55M |
| 4 |
Verizon
VZ
|
+$1.04M |
| 5 |
Philip Morris
PM
|
+$809K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.14% |
| 2 | Consumer Discretionary | 16.55% |
| 3 | Technology | 16.32% |
| 4 | Communication Services | 12.04% |
| 5 | Healthcare | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Altria Group
MO
$115B
| $1.9M | 0.22% |
33,521
-2,734
| -8% | -$158K |
|
77
SLB Ltd
SLB
$85.1B
| $1.87M | 0.22% |
27,907
-2,420
| -8% | -$166K |
|
78
NVIDIA
NVDA
$5.25T
| $1.86M | 0.22% |
314,360
+9,360
| +3% | +$56.9K |
|
|
FISV
79
Fiserv Inc
FISV
$28.3B
| $1.86M | 0.22% |
25,075
-265
| -1% | -$19.2K |
|
80
IBM
IBM
$222B
| $1.83M | 0.22% |
13,736
-969
| -7% | -$135K |
|
81
Costco
COST
$419B
| $1.83M | 0.21% |
8,757
-115
| -1% | -$22.7K |
|
82
Idexx Laboratories
IDXX
$43.7B
| $1.78M | 0.21% |
8,186
-990
| -11% | -$204K |
|
83
Invesco
IVZ
$14.5B
| $1.78M | 0.21% |
67,091
-6,015
| -8% | -$173K |
|
|
ESRX
84
DELISTED
Express Scripts Holding Company
ESRX
| $1.76M | 0.21% |
22,853
| – | – |
|
85
AT&T
T
$178B
| $1.74M | 0.2% |
71,924
+10,893
| +18% | +$273K |
|
|
GWPH
86
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.71M | 0.2% |
12,256
-387
| -3% | -$55K |
|
87
Union Pacific
UNP
$183B
| $1.66M | 0.19% |
11,716
-1,637
| -12% | -$228K |
|
88
Scotiabank
BNS
$113B
| $1.61M | 0.19% |
28,170
-175
| -0.6% | -$10.5K |
|
89
GeoPark
GPRK
$638M
| $1.61M | 0.19% |
78,212
-36,064
| -32% | -$569K |
|
|
SHLM
90
DELISTED
Schulman (A.) Inc
SHLM
| $1.58M | 0.19% |
35,500
| – | – |
|
91
Medtronic
MDT
$117B
| $1.57M | 0.18% |
18,357
-485
| -3% | -$40.5K |
|
92
Nike
NKE
$58.7B
| $1.48M | 0.17% |
18,633
+279
| +2% | +$19.7K |
|
93
British American Tobacco
BTI
$121B
| $1.45M | 0.17% |
28,818
-3,624
| -11% | -$191K |
|
94
Bristol-Myers Squibb
BMY
$136B
| $1.43M | 0.17% |
25,899
-2,366
| -8% | -$128K |
|
95
Kimberly-Clark
KMB
$36.4B
| $1.42M | 0.17% |
13,447
-3,997
| -23% | -$415K |
|
96
Danaher
DHR
$152B
| $1.4M | 0.16% |
15,979
-3,006
| -16% | -$268K |
|
97
ICU Medical
ICUI
$4.38B
| $1.32M | 0.16% |
4,497
| – | – |
|
98
Universal Display
OLED
$3.81B
| $1.3M | 0.15% |
15,130
| – | – |
|
|
WBA
99
DELISTED
Walgreens Boots Alliance
WBA
| $1.28M | 0.15% |
21,394
-326
| -2% | -$21K |
|
100
Signet Jewelers
SIG
$3.21B
| $1.25M | 0.15% |
22,456
-494
| -2% | -$21.8K |
|
Similar funds
AP
AWM
FWM
BRWM
BDWM
DHFB
MCM
TFM
RBC Europe's Q2 2018 Portfolio in Review
As of Q2 2018, RBC Europe held 1,206 positions worth $852M, up 4.2% from $817M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
RBC Europe's Q2 2018 filing shows 80 new, 123 increased, 188 reduced and 61 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K. The largest sale was Celgene Corp, an estimated $4.54M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
- RBC Europe's largest Q2 2018 buy was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K.
- RBC Europe added most to Berkshire Hathaway Class B in Q2 2018, an estimated $4.02M increase.
- RBC Europe's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $4.54M.
- RBC Europe fully exited Monsanto Co in Q2 2018, selling an estimated $1.55M.
- RBC Europe's ten largest holdings make up 41% of its $852M portfolio in Q2 2018.
- RBC Europe opened 80 new positions and closed 61 in Q2 2018.
- RBC Europe's portfolio value rose 4.2% quarter-over-quarter to $852M.
Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.